EXOZEXOZNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank73
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P73
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
3 qtr
Consecutive growthRecovering
PeriodValue
Q3 202551.53%
Q2 202539.65%
Q1 2025-8.77%
Q4 2024-12.88%
Q3 2024204.76%
Q2 2024-14.48%
Q1 2024-49.56%
Q4 20231870.00%
Q3 2023269.18%
Q2 2023-76.05%
Q1 2023-44.87%
Q4 20220.00%